Literature DB >> 16557861

Biological Activities of Rabbit Immunoglobulin M and Immunoglobulin G Antibodies to Pseudomonas aeruginosa.

A B Bjornson1, J G Michael.   

Abstract

Immunoglobulin (Ig)M and IgG antibodies, prepared in the rabbit against the protective antigen of Pseudomonas aeruginosa P4, were compared as to their biological activities in vitro and in vivo. In vitro biological activities of these antibodies were determined by passive hemagglutination, bactericidal, and opsonophagocytic tests. Increased effectiveness of IgM over IgG on a molar basis was demonstrated in all of these tests. However, in mouse protection tests, in which the purified globulins were injected intraperitoneally 4 hr prior to challenge with P. aeruginosa suspended in hog gastric mucin, IgM anticapsular antibody was found to be less effective than IgG antibody. The exact mechanism whereby IgG antibody exerts more protective ability than IgM antibody is still unknown. We present evidence to suggest that the difference in activity between the two classes of antibody is due to the ability of the IgG antibody to enter the bloodstream more rapidly than the IgM antibody and also to the ability of IgG to diffuse rapidly through the tissues of the organs.

Entities:  

Year:  1970        PMID: 16557861      PMCID: PMC416032          DOI: 10.1128/iai.2.4.453-461.1970

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  PSEUDOMONAS VACCINE AND HYPERIMMUNE PLASMA IN THE TREATMENT OF BURNED PATIENTS.

Authors:  I FELLER; I KAMEI
Journal:  Surg Forum       Date:  1964

2.  PSEUDOMONAS INFECTION. TREATMENT WITH IMMUNE PLASMA.

Authors:  D S FEINGOLD; F OSKI
Journal:  Arch Intern Med       Date:  1965-09

3.  Fractionation of human-serum proteins by gel filtration.

Authors:  P FLODIN; J KILLANDER
Journal:  Biochim Biophys Acta       Date:  1962-10-08

4.  Efficacy of rabbit pseudomonas antiserum in experimental Pseudomonas aeruginosa infection.

Authors:  R C MILLICAN; J D RUST
Journal:  J Infect Dis       Date:  1960 Nov-Dec       Impact factor: 5.226

5.  The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis.

Authors:  P V LIU; Y ABE; J L BATES
Journal:  J Infect Dis       Date:  1961 Mar-Apr       Impact factor: 5.226

6.  Prevalence of antibody to Pseudomonas in normal human sera.

Authors:  S GAINES; M LANDY
Journal:  J Bacteriol       Date:  1955-06       Impact factor: 3.490

7.  The antibody activities of 19S and 7S fractions from rabbit antisera to Bordetella pertussis.

Authors:  J M Dolby; D E Dolby
Journal:  Immunology       Date:  1969-06       Impact factor: 7.397

8.  ASSOCIATION OF "NATURAL" ANTIBODIES TO GRAM-NEGATIVE BACTERIA WITH THE GAMMA-1-MACROGLOBULINS.

Authors:  J G MICHAEL; F S ROSEN
Journal:  J Exp Med       Date:  1963-10-01       Impact factor: 14.307

9.  Studies on natural antibodies to gram-negative bacteria.

Authors:  J G MICHAEL; J L WHITBY; M LANDY
Journal:  J Exp Med       Date:  1962-01-01       Impact factor: 14.307

10.  THE ISOLATION AND BIOLOGICAL ACTIVITIES OF RABBIT GAMMA M- AND GAMMA G-ANTI-SALMONELLA TYPHIMURIUM ANTIBODIES.

Authors:  J B ROBBINS; K KENNY; E SUTER
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

View more
  20 in total

1.  Passive protective properties of serum fractions from mice inoculated with an anti-pseudomonas vaccine.

Authors:  R J Jones; M Hall; C R Ricketts
Journal:  Immunology       Date:  1972-12       Impact factor: 7.397

2.  Passive protection of mice against intraperitoneally injected Vibrio cholerae by G and M antibody.

Authors:  R M Pike; C H Chandler
Journal:  Infect Immun       Date:  1971-11       Impact factor: 3.441

Review 3.  Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.

Authors:  P W Taylor
Journal:  Microbiol Rev       Date:  1983-03

4.  Effect of cyclophosphamide on the immune response to Pseudomonas aeruginosa in mice.

Authors:  C L Pierson; A G Johnson; I Feller
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

5.  Serum sensitivity of a Pseudomonas aeruginosa mucoid strain.

Authors:  N L Schiller; M J Alazard; R S Borowski
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

6.  Contribution of humoral and cellular factors to the resistance to experimental infection by Pseudomonas aeruginosa in mice. I. Interaction between immunoglobulins, heat-labile serum factors, and phagocytic cells in the killing of bacteria.

Authors:  A B Bjornson; J G Michael
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

7.  Protection against fatal Pseudomonas aeruginosa burn wound sepsis by immunization with lipopolysaccharide and high-molecular-weight polysaccharide.

Authors:  S J Cryz; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

8.  Glycolipoprotein from Pseudomonas aeruginosa as a protective antigen against P. aeruginosa infection in mice.

Authors:  J W Sensakovic; P F Bartell
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

9.  Contribution of humoral and cellular factors to the resistance to experimental infection by Pseudomonas aeruginosa in mice. II. Opsonic, agglutinative, and protective capacities of immunoglobulin G anti-Pseudomonas antibodies.

Authors:  A B Bjornson; J G Michael
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

10.  Protective ability of antibodies against 78- and 40-kilodalton outer membrane antigens of Haemophilus somnus.

Authors:  R P Gogolewski; S A Kania; H D Liggitt; L B Corbeil
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.